• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, REPLACEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, REPLACEMENT Back to Search Results
Model Number 305_MOSAIC
Device Problems Calcified (1077); Perivalvular Leak (1457); Inadequacy of Device Shape and/or Size (1583); Structural Problem (2506); Torn Material (3024)
Patient Problems Aortic Regurgitation (1716); Aortic Valve Stenosis (1717); Endocarditis (1834); Hemolytic Anemia (2279)
Event Date 03/20/2018
Event Type  Injury  
Manufacturer Narrative
Citation: jessica webb.A comparison of early redo surgery rates in mosaic porcine and perimount bovine pericardial valves.European journal of cardio-thoracic surgery.(b)(6) 2018; 0, 1-5.Doi: 10.1093/ejcts/ezy113 earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature review regarding redo surgery rates of patients with mosaic and perimount valves.All data were collected from a single center between 2000 and 2008.The study population included 1018 patients, 216 of which were implanted with a mosaic valve.Serial numbers were not provided.The mosaic study population was predominantly male; mean age 75 years.Among all patients adverse events included: aortic regurgitation, stenosis, endocarditis, structural (calcification, leaflet tear or stent creep) and non structural valve deterioration (stenosis or regurgitation or haemolysis, e.G.Pannus, patient prosthesis mismatch and paraprosthetic leak) treated with redo surgery.Based on the available information, these events may have been attributed to a medtronic product.However as multiple manufacturers were noted in the literature, a direct correlation could not be made between the observed adverse events and the medtronic product.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, REPLACEMENT
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key7464722
MDR Text Key106617736
Report Number2025587-2018-00987
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Health Professional
Type of Report Initial
Report Date 04/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number305_MOSAIC
Device Catalogue Number305_MOSAIC
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/02/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
-
-